Abstract
Carbon monoxide prodrugs with triggered release profiles are highly desirable for targeted CO delivery to minimize their untoward side-effects. Herein, we describe a series of pH-sensitive metal-free CO prodrugs which are stable under acidic conditions and yet begin to release CO in response to increases in pH with tunable and predictable release rates.
MeSH terms
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / chemical synthesis
-
Anti-Inflammatory Agents, Non-Steroidal / chemistry*
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology
-
Carbon Monoxide / chemistry*
-
Cell Survival / drug effects
-
Dose-Response Relationship, Drug
-
Hydrogen-Ion Concentration
-
Lipopolysaccharides / antagonists & inhibitors
-
Lipopolysaccharides / pharmacology
-
Mice
-
Molecular Structure
-
Prodrugs / chemical synthesis
-
Prodrugs / chemistry*
-
Prodrugs / pharmacology
-
RAW 264.7 Cells
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
-
Tumor Necrosis Factor-alpha / biosynthesis
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Lipopolysaccharides
-
Prodrugs
-
Tumor Necrosis Factor-alpha
-
Carbon Monoxide